Itf Therapeutics LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$342Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
440clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2024 $68K
2025 $274K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Neurology With Special Qualifications In Child Neurology $125K
Neurodevelopmental Disabilities (Pediatrics) $62K
Neuromuscular Medicine (Psychiatry & Neurology) $43K
Neurology (Psychiatry & Neurology) $42K
Physical Medicine & Rehabilitation $27K
Pediatrics $9,304

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Ashutosh Kumar Hershey, PA Neurodevelopmental Disabilities (Pediatrics) $61,496.55
Daniel Guillen Mendoza Memphis, TN Neuromuscular Medicine (Psychiatry & Neurology) $30,536.58
Nassim Rad Seattle, WA Physical Medicine & Rehabilitation $26,853.83
Aravindhan Veerapandiyan Little Rock, AR Neurology With Special Qualifications In Child Neurology $21,363.73
Perry Shieh Los Angeles, CA Neurology (Psychiatry & Neurology) $13,510.57
Chamindra Laverty San Diego, CA Neurology (Psychiatry & Neurology) $12,313.54
Erika Finanger Portland, OR Neurology With Special Qualifications In Child Neurology $10,253.38
Natalie Katz Durham, NC Neurology With Special Qualifications In Child Neurology $10,034.37
John Brandsema Philadelphia, PA Neurology With Special Qualifications In Child Neurology $9,797.38
Diana Castro Denton, TX Neurology With Special Qualifications In Child Neurology $8,842.29

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.